Cataract DME - Peri vs. Intraop

Withdrawn before enrolling · Phase 2

Conditions studied: Diabetic Macular Edema, Cataract

In brief

Goals of the study are to evaluate how peri-operative versus intra-operative anti-VEGF intravitreous injections affect visual acuity (BCVA) in patients with persistent diabetic macular edema who are undergoing cataract surgery; and to evaluate how peri-operative versus intra-operative anti-VEGF intravitreous injections affect OCT CSF thickness and total number of postoperative injections in patients with diabetic macular edema who are undergoing cataract surgery.

Key facts

Study ID

NCT03920878

Run by

Emory University

People needed

0

Starts

2020-05-01

Expected to finish

2020-06-01

Last updated by the study team

2020-12-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults over age 18 with diabetes mellitus, diabetic macular edema and visually significant cataracts planning to undergo cataract surgery

You may not qualify if…

• Patients who have undergone panretinal photocoagulation (PRP) in prior 4 months or an ocular condition (other than cataract and DME) that might affect visual acuity during course of study.
• Patients with history of vitrectomy.
• Patients with neovascular glaucoma.

Where it is running

• Emory Clinic — Atlanta, Georgia, United States
• Grady Health System — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.